Displacement of [125I]Tyr3-neurotensin from human recombinant NTS1 stably expressed in CHO-K1 cell membranes incubated for 60 mins by gamma counter analysis
Displacement of [125I]Tyr3-neurotensin from human recombinant NTS2 stably expressed in human 1321N1 cell membranes incubated for 60 mins by gamma counter analysis
Selectivity index, ratio of Ki for displacement of [125I]Tyr3-neurotensin from human recombinant NTS2 to Ki for displacement of [125I]Tyr3-neurotensin from human recombinant NTS1
Antinociceptive activity in Sprague-Dawley rat model assessed as increased in tail withdrawal latency administered intrathecally measured every 10 mins for 60 mins by radiant heat tail-flick test
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum efficacy causing increase in tail withdrawal latency administered intrathecally measured every 10 mins for 60 mins by radiant heat tail-flick test
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum possible effect at 10 microg/kg, IT measured every 10 mins for 60 mins by radiant heat tail-flick test relative to control
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum possible effect at 30 microg/kg, IT measured every 10 mins for 60 mins by radiant heat tail-flick test relative to control
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum possible effect at 60 microg/kg, IT measured every 10 mins for 60 mins by radiant heat tail-flick test relative to control
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum possible effect at 90 microg/kg, IT measured every 10 mins for 60 mins by radiant heat tail-flick test relative to control
Antinociceptive activity in Sprague-Dawley rat model assessed as maximum possible effect at 150 microg/kg, IT measured every 10 mins for 60 mins by radiant heat tail-flick test relative to control
Antinociceptive activity in Sprague-Dawley rat model assessed as effective dose administered intrathecally and measured every 10 mins for 60 mins by radiant heat tail-flick test
Antinociceptive activity in Sprague-Dawley rat model of formalin-induced nociception pain assessed as reduction in pain behaviour by measuring less lifting of formalin injected hind paw during acute phase at 30 to 150 microg/kg, IT measured for 9 mins
Antinociceptive activity in Sprague-Dawley rat model of formalin-induced nociception pain assessed as reduction in pain behaviour by measuring less lifting of formalin injected hind paw during inflammatory phase at 30 to 150 microg/kg, IT
Antiallodynic activity in Sprague-Dawley rat model of complete Freund's adjuvant-induced chronic inflammatory pain assessed as increase in paw withdrawl threshold at 150 microg/kg, IT dosed on day 7 and 14 measured at 15 to 120 mins post dose relative to control
Induction of hypothermia in Sprague-Dawley rat assessed as reduction in body temperature at 150 microg/kg, IT measured every 10 mins upto 60 mins by thermistor probe analysis
Myorelaxant activity in Sprague-Dawley rat ileum assessed as reduction in carbachol-induced contractions at 10 ^-11 to 10^-5 M by force transducer relaxation assay